Carley E Mejia, P.A. Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 4 Shape Dr, Kennebunk, ME 04043 Phone: 207-467-8930 Fax: 207-467-8969 |
Ms. Erin Susan Welch, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4 Shape Dr, Kennebunk, ME 04043 Phone: 207-467-8930 Fax: 207-985-8459 |
Cassandra June Hotaling-hahn, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2 Livewell Dr, Kennebunk, ME 04043 Phone: 207-467-8988 |
Megan O Bridgeo, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2 Livewell Dr, Kennebunk, ME 04043 Phone: 207-467-8988 |
Ms. Hannah Leigh Richards, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 72 Main St, Kennebunk, ME 04043 Phone: 207-467-8810 Fax: 207-467-8811 |
Walter N Hearn, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 26 Barnard Ln, Kennebunk, ME 04043 Phone: 207-502-7074 |
News Archive
The Atlanta Journal-Constitution: "The health care plan aims to send a wave of paying patients to hospitals, doctors and pharmacists." Expanded coverage will mean less uncompensated care, a boon to traditional safety-net hospitals, but also more Medicaid patients. Hospitals say Medicaid fees don't cover their costs, so that influx could hurt the bottom line.
Non-narcotic treatments for chronic pain that work well in people, not just mice, are sorely needed. Drawing from human pain genetics, an international team led by Boston Children's Hospital demonstrates a way to break the cycle of pain hypersensitivity without the development of addiction, tolerance or side effects.
A study published in the February 2018 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that five novel genetic variants associated with attention-deficit/hyperactivity disorder (ADHD) have been identified by exploiting genetic overlap between ADHD and educational attainment.
UCLA researchers may have found a key to determining which Parkinson's disease patients will experience a more rapid decline in motor function, sparking hopes for the development of new therapies and helping identify those who could benefit most from early intervention.
HemCon Medical Technologies, Inc., announced today that it will appeal a permanent injunction entered by a US District Court in New Hampshire based on a patent held by Marine Polymer Technologies, Inc.
› Verified 1 days ago